Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

InnovAge Lower 4th Straight Day, Targets Cut as Firm Drops Guidance

Published 12/28/2021, 11:47 AM
Updated 12/28/2021, 11:49 AM
© Reuters.

© Reuters.

By Dhirendra Tripathi

Investing.com – InnovAge stock (NASDAQ:INNV) stock tanked 12.5% Tuesday as last week’s shelving of the annual guidance by the company continues to rattle traders.

The stock has more than halved since the December 23 move by the healthcare manager that prompted several brokerages, including Barclays, to cut their ratings and price targets for the stock.

The company’s decision came after the Centers for Medicare and Medicaid Services (CMS) froze enrollment at its Colorado centers based on deficiencies detected in a focused audit.

To make matters worse for the company, the Colorado Department of Health Care Policy and Financing has also issued sanctions against the company.

CMS indicated that the suspension will remain in effect until the company remedies the deficiencies to its satisfaction.

A raft of downgrades followed the company’s decision to withdraw its guidance. According to StreetInsider, Piper Sandler analyst Jeff Garro downgraded InnovAge to neutral with a target of $4. So did Goldman Sachs’ Jamie Perse with the same rating and a similar price target.

 

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.